Dr. H. DE SAMBLANX, Inwendige Geneeskunde SRL
Dr. H. DE SAMBLANX, Inwendige Geneeskunde reported total assets of 904,146 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
By total assets for 2025, Dr. H. DE SAMBLANX, Inwendige Geneeskunde ranks among the 5,000 largest of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. H. DE SAMBLANX, Inwendige Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +40 % Total assets +50 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. H. DE SAMBLANX, Inwendige Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 193,507 € | ||||
| Equity | 845,264 € | ||||
| Cash | 560,147 € | ||||
| EBITDA | 278,978 € | ||||
| Total assets | 904,146 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Dr. H. DE SAMBLANX, Inwendige Geneeskunde's financial analysis
- Solvency93.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. H. DE SAMBLANX, Inwendige Geneeskunde
1 active director(s) in the register.
Dr. H. DE SAMBLANX, Inwendige Geneeskunde's shareholders and holdings →Dr. H. DE SAMBLANX, Inwendige Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0874.469.450
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0874469450 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jun 2005
- Registered office
- 2200 Herentals
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. H. DE SAMBLANX, Inwendige Geneeskunde (SRL) has been based in Herentals since 2005, active in: medical specialists activities. For 2025, it reports a net profit of 193,507 € and equity of 845,264 €; its revenue is not published. Its solvency stands at 93.5%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. H. DE SAMBLANX, Inwendige Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Datafisk Business and other management consultancy activities Zottegem · balance sheet 904,286 €
- ARTE Hasselt · balance sheet 795,046 €
- Dr. E. Draulans Ophtalmologe Medical specialists activities Heist-op-den-Berg · balance sheet 902,715 €
- Vermabo Kuurne · balance sheet 902,667 €
- Wasur Invest Beveren-Kruibeke-Zwijndrecht · balance sheet 902,579 €
- AMV Immo Fléron · balance sheet 903,697 €
- Docteur Mathantu Neupré · balance sheet 903,560 €
Frequently asked questions about Dr. H. DE SAMBLANX, Inwendige Geneeskunde
What is the revenue of Dr. H. DE SAMBLANX, Inwendige Geneeskunde?
Dr. H. DE SAMBLANX, Inwendige Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. H. DE SAMBLANX, Inwendige Geneeskunde?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. H. DE SAMBLANX, Inwendige Geneeskunde. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0874469450. Its company number (CBE) is 0874.469.450.
Where is the registered office of Dr. H. DE SAMBLANX, Inwendige Geneeskunde?
According to the CBE register, the registered office of Dr. H. DE SAMBLANX, Inwendige Geneeskunde is in 2200 Herentals.
What is the equity of Dr. H. DE SAMBLANX, Inwendige Geneeskunde?
At the close of the 2025 financial year, the equity of Dr. H. DE SAMBLANX, Inwendige Geneeskunde amounts to 845,264 €, a solvency of 93.5% of total assets.
Who manages Dr. H. DE SAMBLANX, Inwendige Geneeskunde?
The register lists 1 active mandates at Dr. H. DE SAMBLANX, Inwendige Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. H. DE SAMBLANX, Inwendige Geneeskunde within its sector?
By total assets for 2025, Dr. H. DE SAMBLANX, Inwendige Geneeskunde ranks among the 5,000 largest of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. H. DE SAMBLANX, Inwendige Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →